Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15383)

• Formulation Name: Niraparib 100 mg capsule
• Company: TESARO

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
MK-4827	(DMLYGH4)	Ovarian cancer	2C73	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Erythrosine sodium anhydrous	(E00324)	27872	Colorant
FD&C blue no. 1	(E00263)	19700	Colorant
Gelatin	(E00630)	Not Available	Other agent
Hydrazine yellow	(E00409)	164825	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent